24th Annual Highlights of the 2025 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, our upcoming CME/NCPD program will explore the latest advances from the 2025 San Antonio Breast Cancer Symposium—translating key data into clinical practice for oncologists, gynecologists, radiologists, and other breast cancer care professionals.
The program will explore emerging options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease. In addition, it will highlight new strategies for optimizing existing treatments, with the goal of improving patient outcomes through evidence-based care.
Call for Abstracts
Share your research and be recognized in the Poster Session and Awards!
We invite medical students, residents, fellows, and physician faculty (within 5 years of completing training) to submit abstracts in basic science, translational research, or clinical research in breast cancer.
To submit an abstract for consideration, please send the following by MONDAY, DECEMBER 1, 2025 to lucia.tono-ramirez@tuhs.temple.edu:
- One–page abstract (maximum 500 words). Please structure your abstract as follows: Title, Background, Introduction, Objectives, Methods, Results and Conclusions.
- In the abstract, please specify the name, credential, affiliation, and e-mail of the person who will be presenting the poster. Priority will be given to early abstract submissions. Notifications of abstracts selected will be done by email.
Selected abstracts will be featured during the Poster Session & Awards at the education program on January 15, 2026
PROGRAM DATE:
Thursday, January 15, 2026
TIMES:
5:45–7:00 pm EST Check-In, Reception and Poster Session
(Buffet opens at 6:30)
7:00–9:00 pm EST (Education Program & Dinner)
LOCATION:
Philadelphia Marriott Old City
One Dock Street
Philadelphia, PA 19106
LEARNING OBJECTIVES:
- Analyze the advances in the management of breast cancer and premalignant breast disease and when clinically relevant:
- Integrate new findings into the management of these patients.
- Apply new strategies for optimizing existing treatments into the management of these patients.
- Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.
PROGRAM DIRECTOR & FACULTY:
Angela Jain, MD
Asssociate Professor, Department of Hematology/Oncology;
Interim Chief, Division of Breast Medical Oncology;
Chief, Division of Gynecologic Medical Oncology;
Clinical Director, GYN/Well Women's Health Clinical Service Line;
Fox Chase Cancer Center
PLANNING COMMITTEE:
Michael Seidman, MD
Professor, Department of Hematology/Oncology
Fox Chase Cancer Center
INTENDED AUDIENCE:
The program is designed for medical, surgical, and radiation oncologists; gynecologists; radiologists; fellows; residents; medical school students; advanced practice providers; nurses; and healthcare professionals involved in the treatment of patients with breast cancer.
ACCREDITATION STATEMENT:
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
DESIGNATION STATEMENT:
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 2 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.
INQUIRIES:
Lucía Tono, PhD, MEd